Search for: "Drewes v. State" Results 1 - 20 of 3,209
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 May 2024, 1:23 pm by Amy Howe
  The case began in 2021, when the legislature drew the district at the center of the dispute, known as District 1. [read post]
This term stated that customers must “tell us if anything changes while you’re insured with us” (the Notification Clause) (our emphasis) and was included within Product Disclosure Statements (PDSs) issued with approximately 1,377,900 contracts for home and contents insurance policies. [read post]
16 May 2024, 6:40 am by Second Circuit Civil Rights Blog
Prison cases are difficult to win because the State can always argue that the rights restriction drew from safety concerns. [read post]
8 May 2024, 5:17 am by Jan von Hein
Regarding the possible consequences of Brexit, de la Tour drew two sets of conclusions from the fact that the applicant still holds Romanian nationality. [read post]
30 Apr 2024, 12:25 am by David Pocklington
Ormondroyd Ch was unconvinced by the justification, stating: “[20]. [read post]
In their judgment, the Court of Appeal drew attention to the wording of Article 49(5) stating that the position of the defendant in particular should be taken into account – in circumstances where the outcome of the balancing of interests is equal, then the position of the defendant is the deciding factor. [read post]
18 Apr 2024, 1:44 pm by Patricia Hughes
Round Two: rehearing by the AHRC; an appeal from the AHRC’s 2020 decision (Amir and Siddique v. [read post]
16 Apr 2024, 9:01 pm by Vikram David Amar
A year ago, almost to the day, my (co-authored) Verdict column focused on the lessons to be learned from a high-profile and boisterous protest by Stanford Law School students at a Federalist Society Speaker Event featuring Judge Kyle Duncan, a conservative Trump-appointed judge on the United States Court of Appeals for the Fifth Circuit. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
8 Apr 2024, 12:36 am by centerforartlaw
The European Court of Human Rights in the decision Bayev and others v. [read post]